Symbiox Investment & Trading Co Ltd
Fundamental Score
Symbiox Investment & Trading Co Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SYMBIOX across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Consistent Growth Track Record (21.64% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (56.87% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (56.87% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Below-Average Return on Equity (0.60%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-0.07%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Profit Decline Concern (-81.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-69.33%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Negative Free Cash Flow (₹-3.17 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (3.33%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Symbiox Investment & Trading Co Ltd
About SYMBIOX
Business Overview
Symbiox Investment & Trading Co Ltd engages in the trading of textile products in India. The company offers traditional handloom, handicrafts, wool and silk products; garments, gunny, hessian, carper backing, tarpoline cloth, jute cutting, raw jute, and textile; and fabrics, carpets, durries, mats, rugs, blankets, shawls, tweeds, linens, flannels, bed spreads, quilts, scares, belts, polyester, fiber, yarn, hosiery and mixed fabrics natural silk fabrics and garments, as well as furnishing and all sorts of apparels dressing materials mixed nylon. It deals in shares, stocks, debentures, bonds, and obligations and securities issued or guarantees. The company sells its products through wholesalers and retailers. Symbiox Investment & Trading Co. Ltd. was incorporated in 1979 and is based in Kolkata, India.
Company Details
Key Leadership
SYMBIOX Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Symbiox Investment & Trading Co Ltd (SYMBIOX)?
As of 29 Jan 2026, 10:33 am IST, Symbiox Investment & Trading Co Ltd (SYMBIOX) is currently trading at ₹1.87. The stock has a market capitalization of ₹8.67 (Cr).
Is SYMBIOX share price Overvalued or Undervalued?
SYMBIOX is currently trading at a P/E ratio of 0.00x, compared to the industry average of 30.94x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Symbiox Investment & Trading Co Ltd share price?
Key factors influencing SYMBIOX's price include its quarterly earnings growth (Sales Growth: -69.33%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Symbiox Investment & Trading Co Ltd a good stock for long-term investment?
Symbiox Investment & Trading Co Ltd shows a 5-year Profit Growth of 56.87% and an ROE of 0.60%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Symbiox Investment & Trading Co Ltd compare with its industry peers?
Symbiox Investment & Trading Co Ltd competes with major peers in the Other Financial Services. Investors should compare SYMBIOX's P/E of 0.00x and ROE of 0.60% against the industry averages to determine its competitive standing.
What is the P/E ratio of SYMBIOX and what does it mean?
SYMBIOX has a P/E ratio of N/Ax compared to the industry average of 30.94x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is SYMBIOX performing according to Bull Run's analysis?
SYMBIOX has a Bull Run fundamental score of 22.1/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SYMBIOX belong to?
SYMBIOX operates in the Other Financial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Symbiox Investment & Trading Co Ltd.
What is Return on Equity (ROE) and why is it important for SYMBIOX?
SYMBIOX has an ROE of 0.60%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Symbiox Investment & Trading Co Ltd generates profits from shareholders' equity.
How is SYMBIOX's debt-to-equity ratio and what does it indicate?
SYMBIOX has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is SYMBIOX's dividend yield and is it a good dividend stock?
SYMBIOX offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SYMBIOX grown over the past 5 years?
SYMBIOX has achieved 5-year growth rates of: Sales Growth 21.64%, Profit Growth 56.87%, and EPS Growth 56.87%.
What is the promoter holding in SYMBIOX and why does it matter?
Promoters hold 3.33% of SYMBIOX shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SYMBIOX's market capitalization category?
SYMBIOX has a market capitalization of ₹9 crores, placing it in the Small-cap category.
How volatile is SYMBIOX stock?
SYMBIOX has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SYMBIOX?
SYMBIOX has a 52-week high of ₹N/A and low of ₹N/A.
What is SYMBIOX's operating profit margin trend?
SYMBIOX has a 5-year average Operating Profit Margin (OPM) of -0.07%, indicating the company's operational efficiency.
How is SYMBIOX's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -69.33% and YoY Profit Growth of -81.82%.
What is the institutional holding pattern in SYMBIOX?
SYMBIOX has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.